Cargando…

RNA-guided gene activation by CRISPR-Cas9-based transcription factors

Technologies for engineering synthetic transcription factors have enabled many advances in medicine and science. In contrast to existing methods based on engineering of new DNA-binding proteins, we created a Cas9-based transactivator that is targeted to DNA sequences by guide RNA molecules. Co-expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perez-Pinera, Pablo, Kocak, D. Dewran, Vockley, Christopher M., Adler, Andrew F., Kabadi, Ami M., Polstein, Lauren R., Thakore, Pratiksha I., Glass, Katherine A., Ousterout, David G., Leong, Kam W., Guilak, Farshid, Crawford, Gregory E., Reddy, Timothy E., Gersbach, Charles A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911785/ https://www.ncbi.nlm.nih.gov/pubmed/23892895 http://dx.doi.org/10.1038/nmeth.2600

Ejemplares similares

Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain
por: Kabadi, Ami M., et al.
Publicado: (2014)

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators
por: Polstein, Lauren R., et al.
Publicado: (2015)

Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy
por: Ousterout, David G., et al.
Publicado: (2015)

Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases
por: Ousterout, David G, et al.
Publicado: (2015)

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
por: Kabadi, Ami M., et al.
Publicado: (2014)

Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements
por: Thakore, Pratiksha I., et al.
Publicado: (2015)

Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers
por: Hilton, Isaac B., et al.
Publicado: (2015)

A light-inducible CRISPR/Cas9 system for control of endogenous gene activation
por: Polstein, Lauren R., et al.
Publicado: (2015)

A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification
por: Chakraborty, Syandan, et al.
Publicado: (2014)

Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
por: Ousterout, David G, et al.
Publicado: (2013)

Synergistic and tunable human gene activation by combinations of synthetic transcription factors
por: Perez-Pinera, Pablo, et al.
Publicado: (2013)

RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
por: Thakore, Pratiksha I., et al.
Publicado: (2018)

Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter
por: Dicks, Amanda, et al.
Publicado: (2020)

Increasing the specificity of CRISPR systems with engineered RNA secondary structures
por: Kocak, D. Dewran, et al.
Publicado: (2019)

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage
por: Josephs, Eric A., et al.
Publicado: (2016)

Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage
por: Josephs, Eric A., et al.
Publicado: (2015)

Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases
por: Perez-Pinera, Pablo, et al.
Publicado: (2012)

Light-Inducible Spatiotemporal Control of Gene Activation by Customizable Zinc Finger Transcription Factors
por: Polstein, Lauren R., et al.
Publicado: (2012)

AP-1 subunits converge promiscuously at enhancers to potentiate transcription
por: Seo, Jungkyun, et al.
Publicado: (2021)

CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome
por: Klann, Tyler S., et al.
Publicado: (2017)

Targeted genome and epigenome editing using engineered TALE and CRISPR/Cas9 technologies
por: Gersbach, Charles A
Publicado: (2014)

Glucocorticoid receptor recruits to enhancers and drives activation by motif-directed binding
por: McDowell, Ian C., et al.
Publicado: (2018)

Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs
por: Brunger, Jonathan M., et al.
Publicado: (2017)

1083. Phase 1b Results of Pharmacokinetics, Pharmacodynamics, and Safety for LBP-EC01, a CRISPR-Cas3 Enhanced Bacteriophage Cocktail Targeting Escherichia coli that Cause Urinary Tract Infections
por: Kim, Paul, et al.
Publicado: (2021)

Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells
por: Pickar-Oliver, Adrian, et al.
Publicado: (2019)

Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators
por: Kwon, Jennifer B., et al.
Publicado: (2020)

Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies
por: Manandhar, Dinesh, et al.
Publicado: (2017)

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
por: Selle, Kurt, et al.
Publicado: (2020)

Homing in on a biological joint replacement
por: Guilak, Farshid
Publicado: (2010)

Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma
por: Huang, Jianguo, et al.
Publicado: (2017)

Bidirectional approaches for optogenetic regulation of gene expression in mammalian cells using Arabidopsis cryptochrome 2
por: Pathak, Gopal P., et al.
Publicado: (2017)

HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute
por: Lao, Yeh‐Hsing, et al.
Publicado: (2018)

The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)

Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects
por: Deng, Shaohui, et al.
Publicado: (2020)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
por: Ho, Tzu-Chieh, et al.
Publicado: (2021)

CRISPR-Cas Genome Surgery in Ophthalmology
por: DiCarlo, James E., et al.
Publicado: (2017)

Improved genome editing by an engineered CRISPR-Cas12a
por: Ma, Enbo, et al.
Publicado: (2022)

CRISPR/Cas9 and Nanotechnology Pertinence in Agricultural Crop Refinement
por: Naik, Banavath Jayanna, et al.
Publicado: (2022)

CRISPR/Cas9-based depletion of 16S ribosomal RNA improves library complexity of single-cell RNA-sequencing
por: Wang, Kuang-Tse, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j81qmgalnk5i04upkiod6ir6e1